Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Total Revenue of $1.25 million for the year ending 2024.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed an increase of +42.0% in Total Revenue from 2023 to 2024.
- This data is from Cordyceps Sunshine Biotech Holdings Co., Ltd.'s annual report (Form 10-K), filed with the SEC on June 13, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2021 to 2024), Cordyceps Sunshine Biotech Holdings Co., Ltd.'s Total Revenue has grown by 42.6%.
- Historical annual values: Fiscal year 2024: $1.25 million | Fiscal year 2023: $882.5 thousand | Fiscal year 2022: $53.3 thousand | Fiscal year 2021: $879.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: